Clinical Trials Directory

Trials / Completed

CompletedNCT02842697

Virtual Hepatic Venous Pressure Gradient (vHVPG) With CT Angiography (CHESS1601)

Virtual Hepatic Venous Pressure Gradient (vHVPG) With CT Angiography (CHESS1601): A Prospective Multicenter Study for the Noninvasive Diagnosis of Portal Hypertension

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
102 (actual)
Sponsor
Nanfang Hospital, Southern Medical University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a prospective, multi-center trial conducted at 1 Guangzhou and 2 Beijing centers designed to determine the diagnostic performance of virtual hepatic venous pressure gradient (vHVPG) (investigational technology) by anatomic computed tomographic angiography (CTA) for non-invasive assessment of the clinically significant portal hypertension (CSPH) in patients with compensated cirrhosis. Direct hepatic venous pressure gradient (HVPG) measurement by means of catheterization of a hepatic vein with a balloon catheter is the gold-standard method to assess the presence of CSPH, which is defined as HVPG≥10 mmHg.

Detailed description

This is a prospective, multi-center trial conducted at 1 Guangzhou (Nanfang Hospital) and 2 Beijing (Beijing 302 Hospital, Beijing Shijitan Hospital) centers designed to determine the diagnostic performance of vHVPG (investigational technology) by anatomic CTA for non-invasive assessment of the CSPH in patients with compensated cirrhosis. Direct HVPG measurement by means of catheterization of a hepatic vein with a balloon catheter is the gold-standard method to assess the presence of CSPH, which is defined as HVPG≥10 mmHg.

Conditions

Interventions

TypeNameDescription
PROCEDUREHVPG measurementHVPG obtained by means of catheterization of a hepatic vein with a balloon catheter
PROCEDURECTAThree-dimensional hepatic vein-portal vein model constructed with CTA images
PROCEDUREDoppler ultrasoundPortal vein velocity measured by Doppler ultrasound

Timeline

Start date
2016-08-01
Primary completion
2017-04-01
Completion
2017-04-01
First posted
2016-07-25
Last updated
2019-01-08

Locations

3 sites across 1 country: China

Source: ClinicalTrials.gov record NCT02842697. Inclusion in this directory is not an endorsement.